Admission Date:  [**2198-10-19**]       Discharge Date:  [**2198-11-2**]  Date of Birth:   [**2133-2-15**]       Sex:  F  Service:  CHIEF COMPLAINT:  Ms. [**Known lastname 45354**] was admitted to the surgical service for an evaluation of an acute abdomen, and then subsequently transferred to neurology for further management of her myasthenia [**Last Name (un) 2902**].
She continues to do well with soft solids and liquids.
She is currently on CellCept for long-term immune suppression.
PAST MEDICAL HISTORY:  1) Myasthenia [**Last Name (un) 2902**] as above, 2) Status post thymectomy several weeks ago, 3) Hypertension, 4) Mild steroid induced glucose intolerance.
MEDICATIONS:  1) prednisone 80 mg po qd, 2) CellCept 1 gm po bid, 3) Mestinon 30 mg po q 4 h, 4) Glucotrol 2.5 mg po qd.
Abdomen - positive bowel sounds, soft, nontender, nondistended, but obese.
She was started on Protonix [**Hospital1 **] for treatment.
She had an episode of decreased hematocrit that was significant; therefore, she was transferred to the Intensive Care Unit for closer monitoring, and received several units of packed red blood cells and FFP.
Regarding her myasthenia, she was begun on a course of plasmapheresis, and FFP was given after plasmapheresis.
She will also likely need cholecystectomy in the near-future.
At the time of discharge, Ms. [**Known lastname 45354**] is clinically stable and appropriate for discharge home with intent of ERCP and cholecystectomy in several week's time.
DISCHARGE MEDICATIONS:  1) Protonix 40 mg po bid, 2) Mestinon 60 mg po q 6 h, 3) Imuran 25 mg po bid, 4) prednisone 80 mg po qd, 5) Levofloxacin 500 mg po qd until ERCP, 6) glyburide 2.5 mg po qd.
FOLLOW-UP:  1) Ms. [**Known lastname 45354**] will follow-up with Dr. [**First Name (STitle) **] [**Name (STitle) **] in GI.
